| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/29/2002 | US20020119949 Prophylactic teat treatment |
| 08/29/2002 | US20020119947 Blood disorders; autoimmune disease; psychological disorders |
| 08/29/2002 | US20020119946 Formative agent of protein complex |
| 08/29/2002 | US20020119941 In-situ gel formation of pectin |
| 08/29/2002 | US20020119582 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 08/29/2002 | US20020119473 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer |
| 08/29/2002 | US20020119239 Acidic oil-in-water type emulsion composition |
| 08/29/2002 | US20020119207 For decontaminating areas, samples, solutions, and foodstuffs colonized or otherwise infected by pathogens and microorganisms |
| 08/29/2002 | US20020119206 Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions |
| 08/29/2002 | US20020119205 Therapy; as disinfectant for skin or other body surfaces or body cavities; incorporated into bandages, films, sutures; non-staining |
| 08/29/2002 | US20020119203 Preparing first phase comprising nucleophilic active agent, a polymer and solvent; combining with second phase in a static mixer to form emulsion; extracting solvent from the emulsion, thereby forming microparticles |
| 08/29/2002 | US20020119202 For therapy of cancer and other angiogenic-dependent diseases |
| 08/29/2002 | US20020119200 Dispersing drug in a suitable volume of a liquid dispersion medium to form a suspension; bringing together in a vessel grinding media, magnetically activatable means for stirring and the suspension; magnetically activating; separation |
| 08/29/2002 | US20020119198 For manufacture of a medicament for therapeutic treatment, such as steroidal, antifungal, antibacterial, or anticancer treatment |
| 08/29/2002 | US20020119197 For providing uniform dosing over a prolonged period following a single administration |
| 08/29/2002 | US20020119193 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 08/29/2002 | US20020119190 Oil-free pharmaceutical compositions containing cyclosporin A |
| 08/29/2002 | US20020119187 Useful to induce analgesia |
| 08/29/2002 | US20020119169 For use in cosmetic applications, applications in crop protection, for cleaners or food supplements |
| 08/29/2002 | US20020119163 Methods and compositions for protection against bovine viral deseases |
| 08/29/2002 | US20020119157 For cancer therapy |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119149 Multivalent T cell receptor complexes |
| 08/29/2002 | US20020119144 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 08/29/2002 | US20020119120 Amino acid substitution mutants of interleukin 13 |
| 08/29/2002 | US20020119117 Modulated release particles for aerosol delivery |
| 08/29/2002 | US20020119115 Nitric oxide-releasing medical devices |
| 08/29/2002 | US20020119111 For use in cosmetics, drug delivery systems for topical application of medicine that are to be applied to the skin |
| 08/29/2002 | US20020119104 Treatment of mucositis |
| 08/29/2002 | US20020119095 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
| 08/29/2002 | DE10164343A1 Tablettierfähige Zusammensetzung mit Natrium Fosinopril Tabletting flowing composition with fosinopril sodium |
| 08/29/2002 | DE10108387A1 Kosmetisches oder pharmazeutisches Mittel Cosmetic or pharmaceutical composition |
| 08/29/2002 | DE10107240A1 Gelemulsionen in Form von O/W-Emulsionen mit einem Gehalt an Hydrokolloiden Gel emulsions in the form of O / W emulsions with a content of hydrocolloids |
| 08/29/2002 | DE10107165A1 Thermolabiles Liposom mit geregelter Freigabetemperatur Thermolabile liposome with controlled release temperature |
| 08/29/2002 | DE10106971A1 Arzneimittelformulierung die einen muskarinischen Agonisten enthält Pharmaceutical formulation containing a muscarinic agonist |
| 08/29/2002 | DE10065478C1 Kreatin/Citronensäure-Verbindung, Verfahren zu ihrer Herstellung und Verwendung Creatine / citric acid combination, processes for their preparation and use |
| 08/29/2002 | CA2476397A1 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | CA2440197A1 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | CA2438519A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2437989A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/29/2002 | CA2437986A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/29/2002 | CA2436399A1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 08/29/2002 | CA2435378A1 Urine incontinence device and corresponding method |
| 08/29/2002 | CA2434647A1 Cubic liquid crystalline compositions and methods for their preparation |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | CA2426811A1 Novel formulations of carvedilol |
| 08/28/2002 | EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 08/28/2002 | EP1234586A2 Hepatoselective pharmaceutical actives |
| 08/28/2002 | EP1234585A2 Methods and compositions for the prevention or treatment of cancer |
| 08/28/2002 | EP1234584A1 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 08/28/2002 | EP1234583A1 PEG-conjugates of HGF-NK4 |
| 08/28/2002 | EP1234573A1 Anti-inflammatory pharmaceutical compositions and their manufacturing process |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234033A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233969A2 Mono- and disaccharide derivatives |
| 08/28/2002 | EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 08/28/2002 | EP1233794A1 A bioabsorbable drug delivery system |
| 08/28/2002 | EP1233791A2 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 08/28/2002 | EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/28/2002 | EP1233784A2 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 08/28/2002 | EP1233770A2 Phosphonate compounds |
| 08/28/2002 | EP1233767A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 08/28/2002 | EP1233764A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 08/28/2002 | EP1233763A1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 08/28/2002 | EP1233762A1 Patch therapeutic agent delivery device having texturized backing |
| 08/28/2002 | EP1233761A1 Osmotic dosage form comprising first and second coats |
| 08/28/2002 | EP1233757A2 Aerosol composition comprising formoterol |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | EP1233754A2 Targeted drug delivery with a cd44 receptor ligand |
| 08/28/2002 | EP1233753A1 Composition and method for treatment of otitis media |
| 08/28/2002 | EP1233752A2 Radiation sensitive liposomes |
| 08/28/2002 | EP1233751A1 Sustained percutaneous delivery of a biologically active substance |
| 08/28/2002 | EP1233750A1 Novel positive latex and use in cosmetics |
| 08/28/2002 | EP1233746A1 Use of a buffer to prevent candida albicans infections on the skin |
| 08/28/2002 | EP1233681A1 Phytosterol and phytostanol compositions |
| 08/28/2002 | EP1067898A4 Artificial nail compositions and related methods |
| 08/28/2002 | EP0974350B1 External preparation containing tranilast and process for producing the same |
| 08/28/2002 | EP0928201B1 Novel glycolipid complexes and their uses |
| 08/28/2002 | EP0885189B1 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/2002 | EP0806933B1 Formulations and methods for reducing skin irritation |
| 08/28/2002 | EP0800387B1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 08/28/2002 | EP0795134B1 Stabilized aqueous steroid immunoassay standards |
| 08/28/2002 | EP0772452B1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii |
| 08/28/2002 | EP0700284B1 Controlled release oxybutynin formulations |
| 08/28/2002 | EP0671905B1 Stable protein: phospholipid compositions and methods |
| 08/28/2002 | EP0611567B1 Ultrafine powder for inhalation and production thereof |
| 08/28/2002 | CN1089775C Polyblend of structured copolymers used as absorbents, gels and carriers of metal ions |
| 08/28/2002 | CN1089606C Conjugate between modified superantigen and target-seeking compound and use of conjugate |
| 08/28/2002 | CN1089589C Laryngeal bactericidal and antiseptic composition |
| 08/28/2002 | CN1089587C Stable cross-linked compound of polyvinyl pyrrolidone and iodine and method for preparation of said compound |
| 08/28/2002 | CN1089583C Mycophenolate mofetil high dose oral suspensions |
| 08/28/2002 | CN1089582C Agent for slow releasing medicine |
| 08/28/2002 | CN1089581C Pharmaceutical preparation comprising lyophilized lipsomes encapsulating active principle which is highly insoluble in water, and process for preparing said preparation |